lancononelogo

banner

In July 2015, US-FDA increased their existing warning about serious health risks of pain killer drugs even during short term usage such as heart attacks and strokes. In such situation, Lanconone® becomes world’s first clinically proven natural alternative for rapid relief from day-to-day aches and pain at par with Ibuprofen 400mg.

Prospective, double blind, parallel group, multi-center, randomized clinical trial designed by researchers of Enovate Biolife and University of Southern California was conducted in 71 subjects.This new data published in Trials journal during March 2016, demonstrated that Lanconone® provided meaningful pain relief at 196.59 mins which was comparable to meaningful pain relief at 167.13 mins in subjects taking Ibuprofen (400 mg). The meaningful pain relief continued for 6 hours. Meaningful pain relief is a critical endpoint in pain studies. The American Pain Society has stated that a pain-relieving effect, although statistically significant, is irrelevant if the pain relief is not meaningful to the patients. At the end of 6 hours, 88.9% of the Lanconone® subjects showed ≥50% pain relief as compared to 91.4% for the Ibuprofen with no significant difference between the groups (p>0.05).

Earlier 12-week pilot study, published in American Journal of Therapeutics had demonstrated significant improvement in joint pain and stiffness. Importantly this study demonstrated sustained efficacy for 6 weeks even after discontinuation of treatment.

lanconone premium

 

select

 

 

 

 

 

 


Lanconone® reduces swelling and stiffness of pain by reducing key inflammatory markers such as COX2, prostaglandins and interleukins. It also modifies body’s degenerative response to joint wear and tear by down-regulating various members of matrix metalloproteinases (MMPs).

Lanconone® works by itself and also very well complements other joint health ingredients (like glucosamine, chondroitin) for superior joint comfort. Lanconone is particularly well suited for athletes and those with aging or stressed joints.

lanconone-logo11 (1) Request complete clinical study report 

The statements on this website have not been evaluated by the Food and Drug Administration. The products are not intended to diagnose, treat, cure or prevent disease. The technical content and claims provided on this website for business information purposes only and should be reviewed by your legal counsel prior to use in marketing materials, including product labels. Some of these statements may not be applicable to your markets or regulations since it is intended for various geographies around the world